Israel’s Todos (see here previously) completed a Phase 2 study of its Tollovir treatment on 31 hospitalized Covid-19 patients. Their clinical improvement was 2.7 days faster than the placebo group. Jerusalem’s Shaare Zedek hospital is now allowing Tollovir for compassionate use.

https://www.israel21c.org/covid-19-antiviral-drug-shows-promising-results/